Abstract
The NIH Chemical Genomics Center (NCGC) was the inaugural center of the Molecular Libraries and Screening Center Network (MLSCN). Along with the nine other research centers of the MLSCN, the NCGC was established with a primary goal of bringing industrial technology and experience to empower the scientific community with small molecule compounds for use in their research. We intend this review to serve as 1) an introduction to the NCGC standard operating procedures, 2) an overview of several of the lessons learned during the pilot phase and 3) a review of several of the innovative discoveries reported during the pilot phase of the MLSCN.
Current Topics in Medicinal Chemistry
Title: The Pilot Phase of the NIH Chemical Genomics Center
Volume: 9 Issue: 13
Author(s): Craig J. Thomas, Douglas S. Auld, Ruili Huang, Wenwei Huang, Ajit Jadhav, Ronald L. Johnson, William Leister, David J. Maloney, Juan J. Marugan, Sam Michael, Anton Simeonov, Noel Southall, Menghang Xia, Wei Zheng, James Inglese and Christopher P. Austin
Affiliation:
Abstract: The NIH Chemical Genomics Center (NCGC) was the inaugural center of the Molecular Libraries and Screening Center Network (MLSCN). Along with the nine other research centers of the MLSCN, the NCGC was established with a primary goal of bringing industrial technology and experience to empower the scientific community with small molecule compounds for use in their research. We intend this review to serve as 1) an introduction to the NCGC standard operating procedures, 2) an overview of several of the lessons learned during the pilot phase and 3) a review of several of the innovative discoveries reported during the pilot phase of the MLSCN.
Export Options
About this article
Cite this article as:
Thomas J. Craig, Auld S. Douglas, Huang Ruili, Huang Wenwei, Jadhav Ajit, Johnson L. Ronald, Leister William, Maloney J. David, Marugan J. Juan, Michael Sam, Simeonov Anton, Southall Noel, Xia Menghang, Zheng Wei, Inglese James and Austin P. Christopher, The Pilot Phase of the NIH Chemical Genomics Center, Current Topics in Medicinal Chemistry 2009; 9 (13) . https://dx.doi.org/10.2174/156802609789753644
DOI https://dx.doi.org/10.2174/156802609789753644 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bisphosphonates as Treatment of Bone Metastases
Current Pharmaceutical Design Imaging Epigenetics in Alzheimer’s Disease
Current Pharmaceutical Design Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk
Anti-Cancer Agents in Medicinal Chemistry Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Current Cancer Drug Targets Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors
Current Pharmaceutical Design Editorial (Thematic Issue: Thyroid Cancer in Children and Adolescents)
Current Pediatric Reviews Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Current Genomics Ghrelin and Energy Balance: Focus on Current Controversies
Current Drug Targets Protein Pool Maintenance During Oxidative Stress
Current Pharmaceutical Design Pulmonary Arterial Hypertension
Current Vascular Pharmacology Current Development of Metal Complexes with Diamine Ligands as Potential Anticancer Agents
Current Medicinal Chemistry Chronic Diseases and COVID-19: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets The CNS Melanocortin System: A Biological Weapon Against the Threat of Obesity
Current Medicinal Chemistry - Central Nervous System Agents The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors
Current Drug Metabolism Rikkunshito and Ghrelin Secretion
Current Pharmaceutical Design The Effects of Tamoxifen on Immunity
Current Medicinal Chemistry Homology-Free Prediction of Functional Class of Proteins and Peptides by Support Vector Machines
Current Protein & Peptide Science Therapeutic Approaches of Leptin in Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiating Between Primary Tumor, Metastatic Node and Normal Tissue in Head and Neck Cancer
Current Medical Imaging